SoftOx Solutions AS (SoftOx), a clinical-stage biopharmaceutical and medical technology company based inNorway , announces that it will attend and host an educational symposium at theEuropean Wound Management Association (EWMA) Conference inParis, France , from23-25 May 2022 .The European Wound Management Association (EWMA) is a European not-for-profit umbrella organisation, linking national wound management organisations, individuals and groups with interest in wound care. EWMA was established in 1991 as a charity organisation registered in theUK . The EWMA is focused on supporting the implementation of interdisciplinary and cost effective wound care of high quality. EWMA works to reach its objectives by being an educational resource, organising conferences, contributing to international projects related to wound management, actively supporting the implementation of existing knowledge within wound management, and providing information on all aspects of wound management. SoftOx will be hosting a symposium titled 'Future practical solutions for fighting antimicrobial resistance in wound care', which will take place on Wednesday,25 May 2022 , from 12.15-13.15 CEST. "Microbial resistance is one of the most major threats to human health. Navigating this challenging field of research, we are excited to host a symposium homing in on how we manage antimicrobial resistance in wound care and, importantly, promising and cutting-edge research," said Geir Almås, CEOSoftOx Solutions AS . At the Joint EWMA & JournéesCicatrisations Conference , SoftOx will be an exhibitor and presenter. The SWIS-02 study has been selected for oral presentation by its principal investigator, and CEOGeir Almås will present on theEXCITE International approach and participate in a meet-the-experts session as anEXCITE International advisory council member. Symposium details: Title: Future practical solutions for fighting antimicrobial resistance in wound care Date and time: Wednesday,25 May 2022 , 12:15 - 13:15 hrs Speakers and agenda: o Prof.Niels Frimodt-Møller (Rigshospitalet,Dept. of Clinical Microbiology ,Copenhagen , DK) Antimicrobial resistance in your practice: an ever more powerful adversary o Prof. Thomas Bjarnsholt (Copenhagen University Hospital ,Dept. of Clinical Microbiology ,Copenhagen , DK) Countering antimicrobial resistance: its history and mechanism of action o Dr. Klaus Kirketerp-Møller (Wound Healing Center,Bispebjerg University Hospital ,Copenhagen , DK) Fighting antimicrobial resistance in wound care tomorrow: clinical research today Chair:Geir Almås , CEOSoftOx Solutions AS A recording of the symposium will be made available on the Company's website at https://soft-ox.com/investor-presentations/. For further information, visit the EWMA conference website here: https://ewma.org/ewma-conferences/2022 For further information, please contact: Geir Almås, CEO ofSoftOx Solutions AS Mail: ir@soft-ox.com Phone: Front Desk: (+47) 948-59-599 AboutSoftOx Solutions AS SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian biotech/medtech company based inOslo with the aim of helping to combat major threats to human health, namely the emergence of antimicrobial resistance (AMR), biofilm infections in chronic wounds and the spread of viruses. For more information on SoftOx, visit www.soft-ox.com
Click here for more information
© Oslo Bors ASA, source